Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $5.95 Million - $7.57 Million
-177,847 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $3.24 Million - $3.8 Million
102,022 Added 134.55%
177,847 $6.53 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $6.05 Million - $7.33 Million
-200,701 Reduced 72.58%
75,825 $2.48 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $464,213 - $663,259
-17,174 Reduced 5.85%
276,526 $9.03 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.03 Million - $1.17 Million
31,216 Added 11.89%
293,700 $11.5 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $8.53 Million - $11.1 Million
262,484 New
262,484 $9.43 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $1.44 Million - $1.52 Million
-43,200 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $1.34 Million - $1.48 Million
43,200
43,200 $1.54 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $161B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.